首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Hepatoprotective and Anti-Inflammatory Activities of the Cnidoscolus chayamansa (Mc Vaugh) Leaf Extract in Chronic Models
【2h】

Hepatoprotective and Anti-Inflammatory Activities of the Cnidoscolus chayamansa (Mc Vaugh) Leaf Extract in Chronic Models

机译:Cnidoscolus chayamansa(Mc Vaugh)叶提取物在慢性模型中的保肝和抗炎活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous report described that CHCl3:MeOH extract of C. chayamansa leaves and pure compounds (moretenol, moretenyl acetate, kaempferol-3,7-dimethyl ether, and 5-hydroxy-7-3′,4′-trimethoxyflavanone) showed important topical and systemic anti-inflammatory activity in acute model, as well as in vitro antimycobacterial and antiprotozoal activities. In this paper, we describe the in vivo hepatoprotective and anti-inflammatory effects of the CHCl3:MeOH extract in chronic model and the isolation of additional compounds (moretenone and lupeol acetate). The hepatoprotective activity was determined at 39 days using Balb/c mice with liver damage induced with an antitubercular drug (RIF/INH/PZA). The anti-inflammatory activity was evaluated in a chronic model induced with CFA and in two acute models (TPA and carrageenan). In addition, moretenone and lupeol acetate were isolated and identified by spectroscopic data. Lupeol acetate is a main compound present in fractions 14-42, and this fraction was the majority fraction from the extract; from this moretenone was obtained. In animals with liver damage, the extract at 200 and 400 mg/kg induced better body weight gain with respect to positive control (Silymarin); in addition, the mice that received the extract at 200 mg/kg and Silymarin exhibited slight steatosis; however, the animals' livers at 400 mg/kg did not show steatosis. The extract and fractions 14-42 showed a good anti-inflammatory activity by TPA model (DE50 = 1.58 and 1.48 mg/ear) and by carrageenan model (DE50 = 351.53 and 50.11 mg/kg). In the chronic inflammatory test, the extract at three doses revealed a similar effect to that of phenylbutazone, although the body weight gain was better in animals that received the extract at 900 mg/kg. Conclusion. The CHCl3:MeOH extract showed significant anti-inflammatory and good hepatoprotective effect on chronic models. The fraction containing moretenone and lupeol acetate as main compounds was more active than extract in both acute models of inflammation.
机译:先前的报告描述了C.chayamansa叶和纯化合物(摩尔多酚,摩尔多烯乙酸酯,山奈酚3,7-二甲醚和5-羟基-7-3',4'-三甲氧基黄酮)的CHCl3:MeOH提取物显示出重要的局部和在急性模型中具有全身抗炎活性,以及​​体外抗分枝杆菌和抗原生动物活性。在本文中,我们描述了慢性模型中CHCl3:MeOH提取物的体内对肝脏的保护和抗炎作用,以及其他化合物(莫雷酮和醋酸鲁培醇)的分离。使用抗结核药物(RIF / INH / PZA)诱导肝损伤的Balb / c小鼠在39天时测定了肝保护活性。在CFA诱导的慢性模型和两种急性模型(TPA和角叉菜胶)中评估了抗炎活性。此外,分离并通过光谱数据鉴定了甲烯酮和醋酸鲁皮醇。乙酸鲁哌醇是馏分14-42中的主要化合物,该馏分是提取物中的大部分馏分;从该莫雷酮获得。在有肝损伤的动物中,相对于阳性对照(水飞蓟素),提取物以200和400μmg/ kg的剂量诱导更好的体重增加。此外,以200μg/ kg的剂量接受提取物和水飞蓟素的小鼠表现出轻度脂肪变性。但是,动物肝脏的400μmg/ kg脂肪没有脂肪变性。通过TPA模型(DE50 = 1.58和1.48μmg/ ear)和卡拉胶模型(DE50 = 351.53和50.11μmg/ kg),提取物和馏分14-42具有良好的抗炎活性。在慢性炎症试验中,尽管接受900μg/ kg提取物的动物的体重增加更好,但三剂量提取物显示出与苯基丁a相似的效果。结论。 CHCl3:MeOH提取物对慢性模型显示出显着的抗炎作用和良好的肝保护作用。在两种急性炎症模型中,含有莫来酮和醋酸卢培醇作为主要化合物的级分均比提取物更具活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号